BICKAN Trademark
BICKAN is a USPTO trademark filed by OSE Immunotherapeutics. Status: Registered.
Trademark Facts
| Mark | BICKAN |
|---|---|
| Serial Number | 88103678 |
| Registration Number | 6082825 |
| Status | Registered |
| Filing Date | 2018-09-04 |
| Registration Date | 2020-06-23 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT), 044 (Medical Services) |
| Owner | OSE Immunotherapeutics |
| Attorney of Record | Patrick J. Jennings |
| Prosecution Events | 31 |
| Latest Event | REM1 on 2025-06-23 |
Goods & Services
Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; Serums; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing; Provision of medical services; Advice relating to immunology; Therapy services in the nature of therapeutic health care services; Scientific and technological services, namely, research and design in the field of medicine and health; Design and development of software and data bases; Medical research; Research relating to biology and biotechnology; Pharmaceutical research services; Clinical research in the field of cancer and autoimmune diseases; Research and development services in the field of immunology; research and development in the field of microorganisms, cells and antibodies; Research and development of vaccines and medicines; biological analysis; Biological laboratory services; Advice on research and development in the field of therapeutics; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies